To this aim, we investigated human HER2‐positive cancer cell lines, transgenic models, and human tumor specimens at the molecular and metabolic levels using gene expression profiling and high‐resolution magnetic resonance spectroscopy (MRS; Kang et al., 2012). This evidence concerns the gene ERBB2 and neoplasm.